News

FDA approves first blood test to detect Alzheimer’s, marking major breakthrough
Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...
The Scientist4h
Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...
PMLive7h
FDA approves Fujirebio’s Lumipulse as first Alzheimer’s disease blood test
The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...
Onlymyhealth9h
FDA Approves First-Ever Blood Test for Early Alzheimer’s Detection, Replacing Invasive Brain Scans
The FDA has approved the first blood test to detect early Alzheimer’s replacing invasive scans Learn how this game-changing tool could transform diagnosis and treatment ...
New Atlas9h
Breakthrough Alzheimer's blood test has been approved for the US
The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...
KumDi Global Shopping17h
Revolutionary Alzheimer’s Blood Test Approved by FDA in the US
The first blood test for Alzheimer is now FDA-approved. Learn how it helps early detection. Stay informed and act early—read ...
McKnight's Long-Term Care News18h
FDA approves first Alzheimer’s blood test for patients 55+
The US Food and Drug Administration has cleared the first-ever blood test for diagnosing Alzheimer's disease, offering a less ...
FDA approves blood test to detect Alzheimer’s disease
The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by ...
BioWorld21h
Fujirebio Alzheimer’s test wins first FDA clearance
Fujirebio Diagnostics Inc.’s Alzheimer’s disease assay received the U.S. FDA’s first clearance for a blood test for the ...
Healio22h
FDA grants 510(k) clearance to in vitro blood-based Alzheimer’s biomarker device
The FDA has granted 510(k) marketing clearance to the first in vitro blood-based biomarker diagnostic device for Alzheimer’s ...